<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39321170</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Upstream factors impacting COVID-19 vaccination rates across Africa: A systematic review protocol.</ArticleTitle><Pagination><StartPage>e0310884</StartPage><MedlinePgn>e0310884</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0310884</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0310884</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Upstream factors have been found to affect COVID-19 vaccination rates and coverage globally. However, there are inadequate details within the African context. This systematic review aims to close this research gap by investigating upstream factors influencing COVID-19 vaccination rates in Africa.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search will be systematically conducted utilizing various databases including: MEDLINE, EMBASE, SCOPUS, CINAHL, Web of Science, and PsycINFO. Eligible studies will include peer-reviewed articles published in the English language from 2020-2023, conducted in Africa, focused on upstream factors, and include one barrier or facilitator to COVID-19 vaccination rates. Two reviewers will use a two-step screening process to examine every article's title, abstract, and full text. A third-party reviewer will resolve disagreements between both individual reviewers. This review will focus on extracting data from published studies to explain the upstream factors included and their impact on COVID-19 vaccination rates across Africa. Data and records will be managed using Covidence. Preferred Reporting Items for Systematic Reviews and Meta-Analyses [PRISMA] framework will be used as the basis for reporting. To reduce bias, the researchers will use the Mixed Methods Appraisal Tool to assess the studies chosen for review. Results will be compiled utilizing four tables to summarize articles and group determinants based on the Consolidated Framework for Implementation Research (CFIR).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Upstream factors have been cited as affecting population health, vaccination programs, and COVID-19, yet a large-scale systematic review has not been conducted to investigate these factors in relation to COVID-19 vaccination disparities faced in Africa. This review aims to analyze the root causes of African vaccination disparities by focusing on upstream factors. Understanding these factors is vital to help explain why these disparities occur and for designing effective interventions for future vaccinations. The results are expected to provide insights for researchers, policymakers, health systems, and individuals by identifying how resources and efforts can be better utilized to improve vaccination uptake and access.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Systematic review registration: CRD42024501293.</AbstractText><CopyrightInformation>Copyright: © 2024 Ezezika et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ezezika</LastName><ForeName>Obidimma</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-7832-0483</Identifier><AffiliationInfo><Affiliation>Faculty of Health Sciences, Global Health &amp; Innovation Lab, School of Health Studies, University of Western Ontario, London, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>African Centre for Innovation &amp; Leadership Development, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotsaftis</LastName><ForeName>Tiana Stephanie</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Global Health &amp; Innovation Lab, School of Health Studies, University of Western Ontario, London, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marson</LastName><ForeName>Alanna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Western Libraries, Western University, London, London, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39321170</ArticleId><ArticleId IdType="pmc">PMC11423958</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0310884</ArticleId><ArticleId IdType="pii">PONE-D-24-19495</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al.. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021. Jul;5(7):947–53. doi: 10.1038/s41562-021-01122-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01122-8</ArticleId><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Bank. World Bank in Africa. [cited 2024 February 9]. COVID-19 (Coronavirus) Response in Africa. Available from: https://www.worldbank.org/en/region/afr/coronavirus.</Citation></Reference><Reference><Citation>OWID. Number of administered coronavirus (COVID-19) vaccine doses per 100 people in Africa as of March 15, 2023, by country [Internet]. 2023. Available from: https://www.statista.com/statistics/1221298/covid-19-vaccination-rate-in-african-countries/.</Citation></Reference><Reference><Citation>Zbiri S, Boukhalfa C. Inequality in COVID-19 vaccination in Africa. J Public Health Afr. 2023. May 24;14(7):2353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10481897</ArticleId><ArticleId IdType="pubmed">37680874</ArticleId></ArticleIdList></Reference><Reference><Citation>Soulé F. Addressing vaccine inequity: African agency and access to COVID-19 vaccines. China Int Strategy Rev. 2022. June 1;4(1):156–65.</Citation></Reference><Reference><Citation>Ackah BBB, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah UV, et al.. COVID-19 vaccine hesitancy in Africa: a scoping review. Global Health Research and Policy. 2022. Jul 19;7(1):21. doi: 10.1186/s41256-022-00255-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41256-022-00255-1</ArticleId><ArticleId IdType="pmc">PMC9294808</ArticleId><ArticleId IdType="pubmed">35850783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mgongo MB, Manongi RN, Mboya IB, Ngocho JS, Amour C, Mtei M, et al.. A Qualitative Study on Barriers to COVID-19 Vaccine Uptake among Community Members in Tanzania. Vaccines (Basel). 2023. Aug 15;11(8):1366. doi: 10.3390/vaccines11081366</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11081366</ArticleId><ArticleId IdType="pmc">PMC10458528</ArticleId><ArticleId IdType="pubmed">37631934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wollburg P, Markhof Y, Kanyanda S, Zezza A. Assessing COVID-19 vaccine hesitancy and barriers to uptake in Sub-Saharan Africa.
2023. 
Sep
11;3(1). Available from: https://pubmed.ncbi.nlm.nih.gov/37696937/. doi: 10.1038/s43856-023-00330-9

</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-023-00330-9</ArticleId><ArticleId IdType="pmc">PMC10495410</ArticleId><ArticleId IdType="pubmed">37696937</ArticleId></ArticleIdList></Reference><Reference><Citation>Deml MJ, Githaiga JN. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review. BMJ Open. 2022. Nov 1;12(11):e066615. doi: 10.1136/bmjopen-2022-066615</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-066615</ArticleId><ArticleId IdType="pmc">PMC9676416</ArticleId><ArticleId IdType="pubmed">36400736</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydland HT, Friedman J, Stringhini S, Link BG, Eikemo TA. The radically unequal distribution of Covid-19 vaccinations: a predictable yet avoidable symptom of the fundamental causes of inequality. Humanit Soc Sci Commun. 2022. Feb 23;9(1):1–6.</Citation></Reference><Reference><Citation>Rodrigues F, Block S, Sood S. What Determines Vaccine Hesitancy: Recommendations from Childhood Vaccine Hesitancy to Address COVID-19 Vaccine Hesitancy. Vaccines (Basel). 2022. Jan 6;10(1):80. doi: 10.3390/vaccines10010080</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010080</ArticleId><ArticleId IdType="pmc">PMC8780267</ArticleId><ArticleId IdType="pubmed">35062741</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DR, Costa MV, Odunlami AO, Mohammed SA. Moving Upstream: How Interventions that Address the Social Determinants of Health can Improve Health and Reduce Disparities. J Public Health Manag Pract. 2008. Nov;14(Suppl):S8–17. doi: 10.1097/01.PHH.0000338382.36695.42</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PHH.0000338382.36695.42</ArticleId><ArticleId IdType="pmc">PMC3431152</ArticleId><ArticleId IdType="pubmed">18843244</ArticleId></ArticleIdList></Reference><Reference><Citation>Watt RG. From victim blaming to upstream action: tackling the social determinants of oral health inequalities. Community Dentistry and Oral Epidemiology. 2007;35(1):1–11. doi: 10.1111/j.1600-0528.2007.00348.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0528.2007.00348.x</ArticleId><ArticleId IdType="pubmed">17244132</ArticleId></ArticleIdList></Reference><Reference><Citation>Glatman-Freedman A, Nichols K. The effect of social determinants on immunization programs. Human Vaccines &amp; Immunotherapeutics. 2012. Jul 1;8(7):916–20. doi: 10.4161/hv.19003</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.19003</ArticleId><ArticleId IdType="pubmed">22327490</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis MR, Nohynek H, Larson H, Balraj V, Mohan VR, Kang G, et al.. Factors associated with routine childhood vaccine uptake and reasons for non-vaccination in India: 1998–2008. Vaccine. 2018. Oct 22;36(44):6559–66. doi: 10.1016/j.vaccine.2017.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.08.026</ArticleId><ArticleId IdType="pubmed">28844636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, LeClaire AR. A systematic review of factors influencing human papillomavirus vaccination among immigrant parents in the United States. Health Care for Women International. 2019. Jun 3;40(6):696–718. doi: 10.1080/07399332.2017.1404064</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07399332.2017.1404064</ArticleId><ArticleId IdType="pubmed">29161198</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Africa. WHO | Regional Office for Africa.
2021.  [cited 2024 February 18]. Risks and challenges in Africa’s COVID-19 vaccine rollout. Available from: https://www.afro.who.int/news/risks-and-challenges-africas-covid-19-vaccine-rollout.</Citation></Reference><Reference><Citation>Busari DA, Nwokporo EI. Equity, Access and Utilization of COVID-19 Vaccine in Ebonyi State, Nigeria. J geovis spat anal. 2023. Aug 10;7(2):24.</Citation></Reference><Reference><Citation>Naidoo D, Meyer-Weitz A, Govender K. Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review. Vaccines (Basel). 2023. Apr 20;11(4):873. doi: 10.3390/vaccines11040873</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11040873</ArticleId><ArticleId IdType="pmc">PMC10146577</ArticleId><ArticleId IdType="pubmed">37112785</ArticleId></ArticleIdList></Reference><Reference><Citation>Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al.. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94. doi: 10.1038/s41591-021-01454-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01454-y</ArticleId><ArticleId IdType="pmc">PMC8363502</ArticleId><ArticleId IdType="pubmed">34272499</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya KP, Ghimire TR, Subramanya SH. Access to and equitable distribution of COVID-19 vaccine in low-income countries. npj Vaccines. 2021. Apr 14;6(1):1–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047027</ArticleId><ArticleId IdType="pubmed">33854072</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanath K, Bekalu M, Dhawan D, Pinnamaneni R, Lang J, McLoud R. Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health. 2021. Apr 28;21(1):818. doi: 10.1186/s12889-021-10862-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-10862-1</ArticleId><ArticleId IdType="pmc">PMC8081000</ArticleId><ArticleId IdType="pubmed">33910558</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas MR, Alzubaidi MS, Shah U, Abd-Alrazaq AA, Shah Z. A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants. Vaccines. 2021. Nov;9(11):1243. doi: 10.3390/vaccines9111243</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9111243</ArticleId><ArticleId IdType="pmc">PMC8624792</ArticleId><ArticleId IdType="pubmed">34835174</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawshaw AF, Farah Y, Deal A, Rustage K, Hayward SE, Carter J, et al.. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. The Lancet Infectious Diseases. 2022. Sep 1;22(9):e254–66. doi: 10.1016/S1473-3099(22)00066-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00066-4</ArticleId><ArticleId IdType="pmc">PMC9007555</ArticleId><ArticleId IdType="pubmed">35429463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang X. Key factors influencing paediatric COVID-19 vaccine hesitancy: a brief overview and Decision-making Trial and Evaluation Laboratory analysis. Public Health. 2023. May;218:97–105. doi: 10.1016/j.puhe.2022.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2022.11.015</ArticleId><ArticleId IdType="pmc">PMC9701642</ArticleId><ArticleId IdType="pubmed">37003124</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson A, Charles V, Yeung D, Coyle K. The Health Equity Framework: A Science- and Justice-Based Model for Public Health Researchers and Practitioners. Health Promotion Practice. 2021. Nov 1;22(6):741–6. doi: 10.1177/1524839920950730</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1524839920950730</ArticleId><ArticleId IdType="pmc">PMC8564233</ArticleId><ArticleId IdType="pubmed">32814445</ArticleId></ArticleIdList></Reference><Reference><Citation>Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009. August 7;4:50. doi: 10.1186/1748-5908-4-50</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-4-50</ArticleId><ArticleId IdType="pmc">PMC2736161</ArticleId><ArticleId IdType="pubmed">19664226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Alemi F, Yu JV, Hong YA. Social Determinants of COVID-19 Vaccination Rates: A Time-Constrained Multiple Mediation Analysis. Cureus. 15(2):e35110. doi: 10.7759/cureus.35110</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.35110</ArticleId><ArticleId IdType="pmc">PMC10023069</ArticleId><ArticleId IdType="pubmed">36938296</ArticleId></ArticleIdList></Reference><Reference><Citation>Peña JM, Schwartz MR, Hernandez-Vallant A, Sanchez GR. Social and structural determinants of COVID-19 vaccine uptake among racial and ethnic groups. J Behav Med. 2023;46(1–2):129–39. doi: 10.1007/s10865-023-00393-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10865-023-00393-y</ArticleId><ArticleId IdType="pmc">PMC9846662</ArticleId><ArticleId IdType="pubmed">36652085</ArticleId></ArticleIdList></Reference><Reference><Citation>Miner CA, Timothy CG, Percy K, Mashige null, Osuagwu UL, Envuladu EA, et al.. Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers. BMC Public Health. 2023. Jan 28;23(1):191. doi: 10.1186/s12889-023-15116-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15116-w</ArticleId><ArticleId IdType="pmc">PMC9884132</ArticleId><ArticleId IdType="pubmed">36709269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannes K, Harden A. Multi-context versus context-specific qualitative evidence syntheses: combining the best of both. Res Synth Methods. 2011. Dec;2(4):271–8. doi: 10.1002/jrsm.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.55</ArticleId><ArticleId IdType="pubmed">26061890</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>